Evidence map›Paper›PMID 16563424›Full record

ArticleJournal of immunological methods2006

An adenoviral vector for probing promoter activity in primary immune cells.

Pulak Tripathi, Rajat Madan, Claire Chougnet, Senad Divanovic, Xiaojing Ma, Larry M Wahl, Thomas Gajewski, Christopher L Karp, David A Hildeman

Abstract read
In one paragraph

Article in Journal of immunological methods, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Pulak TripathiDivision of Immunobiology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH 45229, USA.
Rajat Madan
Claire Chougnet
Senad Divanovic
Xiaojing Ma
Larry M Wahl
Thomas Gajewski
Christopher L Karp
David A Hildeman
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati · USCornell University · USMay Institute · USNational Institute of Dental and Craniofacial Research · US

Funding

Regulation of Apoptosis in Activated Primary T CellsR01AI057753 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI HILDEMAN, DAVID A · 2005 to 2013
$2.8M
SIGNAL TRANSDUCTION IN THE MONOCYTE/MACROPHAGEZ01DE000456 · NIDCR · NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH · PI WAHL, LARRY M · 1988 to 2008
$1.9M
CD40 Ligand Dysregulation and HIV PathogenesisR01AI056927 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI CHOUGNET, CLAIRE A. · 2005 to 2009
$1.7M
Regulation of IL-12 Expression and Activity by OncogenesR01CA100223 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MA, XIAOJING · 2004 to 2008
$1.5M
IFN BETA AND IMMUNOREGUALTION IN MULTIPLE SCLEROSISR01NS039435 · NINDS · JOHNS HOPKINS UNIVERSITY · PI KARP, CHRISTOPHER L · 2000 to 2003
$1.1M
HEPATITIS C: IFN-ALPHA, IL-12 AND IMMUNOREGULATIONR01DK056415 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI KARP, CHRISTOPHER L · 1999 to 2003
$791k
Regualtion of Apoptosis in Activated Primary T CellsR56AI057753 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI HILDEMAN, DAVID A · 2008 to 2008
$375k
NCI NIH HHS R01 CA100223NIAID NIH HHS AI056927NIAID NIH HHS AI057753NIAID NIH HHS R01 AI056927NIAID NIH HHS R01 AI057753NIAID NIH HHS R56 AI057753NIDDK NIH HHS DK56415NIDDK NIH HHS R01 DK056415NINDS NIH HHS NS39435NINDS NIH HHS R01 NS039435
6 · The paper itself

Abstract

Functional analysis of the DNA regulatory regions that control gene expression has largely been performed through transient transfection of promoter-reporter constructs into transformed cells. However, transformed cells are often poor models of primary cells. To directly analyze DNA regulatory regions in primary cells, we generated a novel adenoviral luciferase reporter vector, pShuttle-luciferase-GFP (pSLUG) that contains a promoterless luciferase cassette (with an upstream cloning site) for probing promoter activity, and a GFP expression cassette that allows for the identification of transduced cells. Recombinant adenoviruses generated from this vector can transduce a wide range of primary immune cells with high efficiency, including human macrophages, dendritic cells and T cells; and mouse T cells transgenic for the coxsackie and adenoviral receptor (CAR). In primary T cells, we show inducible nuclear factor of activated T cells (NF-AT) activity using a recombinant pSLUG adenovirus containing a consensus NF-AT promoter. We further show inducible IL-12/23 p40 promoter activity in primary macrophages and dendritic cells using a recombinant pSLUG adenovirus containing the proximal human IL-12/23 p40 promoter. The pSLUG system promises to be a powerful tool for the analysis of DNA regulatory regions in diverse types of primary immune cells.

Indexed as

AdenoviridaeAnimalsDendritic CellsFlow CytometryGene Expression RegulationGenetic VectorsHumansInterleukin-12Interleukin-2Interleukin-23Interleukin-23 Subunit p19InterleukinsJurkat CellsLuciferasesMacrophagesMiceIL23A protein, humanIl23a protein, mouseInterleukin-12Interleukin-2Interleukin-23Interleukin-23 Subunit p19InterleukinsLuciferasesNFATC Transcription Factors

Identifiers

PMID16563424
PMCPMC2964867
OpenAlexW1983321908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.